Movement Alert｜ASYMCHEM Rises 8.77% in Regular Trading, Goldman Sachs and JPMorgan Both Increase Holdings Ahead of Interim Results

Market Focus08-20

On August 20, ASYMCHEM rose 8.77% in regular trading, reaching HKD 137.6 per share, with turnover of HKD 14.46 million.

The rally was driven by simultaneous position increases from two major international institutions. Goldman Sachs purchased 44,100 H-shares on August 14 at an average price of approximately HKD 116.38, lifting its long position to 1.42 million shares or 5.1%. On the same day, JPMorgan Chase acquired 108,000 shares at approximately HKD 117.32, raising its long position to 2.61 million shares or 9.37%.

Additionally, the company is set to disclose its interim results for the six months ended June 30 on August 24, with institutional views broadly bullish. On August 20, ASYMCHEM held an extraordinary general meeting to approve a RMB 1.24 billion capital injection into its biologic subsidiary and equity incentive plans. The CXO sector continues its rebound trajectory, with multiple positive catalysts converging to fuel the stock's recovery from prior weakness.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1159924724?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-20 09:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1159924724","market":"us","top_or_hot":-1,"title":"Movement Alert｜ASYMCHEM Rises 8.77% in Regular Trading, Goldman Sachs and JPMorgan Both Increase Holdings Ahead of Interim Results","media":"Market Focus","content":"<p><p>On August 20, ASYMCHEM rose 8.77% in regular trading, reaching HKD 137.6 per share, with turnover of HKD 14.46 million.</p><p>The rally was driven by simultaneous position increases from two major international institutions. Goldman Sachs purchased 44,100 H-shares on August 14 at an average price of approximately HKD 116.38, lifting its long position to 1.42 million shares or 5.1%. On the same day, JPMorgan Chase acquired 108,000 shares at approximately HKD 117.32, raising its long position to 2.61 million shares or 9.37%.</p><p>Additionally, the company is set to disclose its interim results for the six months ended June 30 on August 24, with institutional views broadly bullish. On August 20, ASYMCHEM held an extraordinary general meeting to approve a RMB 1.24 billion capital injection into its biologic subsidiary and equity incentive plans. The CXO sector continues its rebound trajectory, with multiple positive catalysts converging to fuel the stock's recovery from prior weakness.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜ASYMCHEM Rises 8.77% in Regular Trading, Goldman Sachs and JPMorgan Both Increase Holdings Ahead of Interim Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜ASYMCHEM Rises 8.77% in Regular Trading, Goldman Sachs and JPMorgan Both Increase Holdings Ahead of Interim Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-08-20 09:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On August 20, ASYMCHEM rose 8.77% in regular trading, reaching HKD 137.6 per share, with turnover of HKD 14.46 million.</p><p>The rally was driven by simultaneous position increases from two major international institutions. Goldman Sachs purchased 44,100 H-shares on August 14 at an average price of approximately HKD 116.38, lifting its long position to 1.42 million shares or 5.1%. On the same day, JPMorgan Chase acquired 108,000 shares at approximately HKD 117.32, raising its long position to 2.61 million shares or 9.37%.</p><p>Additionally, the company is set to disclose its interim results for the six months ended June 30 on August 24, with institutional views broadly bullish. On August 20, ASYMCHEM held an extraordinary general meeting to approve a RMB 1.24 billion capital injection into its biologic subsidiary and equity incentive plans. The CXO sector continues its rebound trajectory, with multiple positive catalysts converging to fuel the stock's recovery from prior weakness.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06821","symbol_name":"凯莱英","start_time":0,"source_url":"","article_id":"1159924724","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1159924724","pubTimestamp":1787189525,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On August 20, ASYMCHEM rose 8.77% in regular trading, reaching HKD 137.6 per share, with turnover of HKD 14.46 million.The rally was driven by simultaneous position increases from two major...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06821":"凯莱英"},"translate_title":"走势提醒|凯莱英常规交易上涨8.77%，高盛和摩根大通在中期业绩公布前均增持","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06821":1},"content_text":"On August 20, ASYMCHEM rose 8.77% in regular trading, reaching HKD 137.6 per share, with turnover of HKD 14.46 million.The rally was driven by simultaneous position increases from two major international institutions. Goldman Sachs purchased 44,100 H-shares on August 14 at an average price of approximately HKD 116.38, lifting its long position to 1.42 million shares or 5.1%. On the same day, JPMorgan Chase acquired 108,000 shares at approximately HKD 117.32, raising its long position to 2.61 million shares or 9.37%.Additionally, the company is set to disclose its interim results for the six months ended June 30 on August 24, with institutional views broadly bullish. On August 20, ASYMCHEM held an extraordinary general meeting to approve a RMB 1.24 billion capital injection into its biologic subsidiary and equity incentive plans. The CXO sector continues its rebound trajectory, with multiple positive catalysts converging to fuel the stock's recovery from prior weakness.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1159924724","isCrawlerRequest":true}